Table 5 Multivariate adjusted odds ratios and 95% confidence intervals for metabolic syndrome and its components across tertiles of MMQI

Hypertriglyceridemia (total)

Crude

1.00

0.76 (0.54,1.07)

0.85 (0.60,1.20)

0.34

Model 1

1.00

0.71 (0.50,1.02)

0.86 (0.60,1.23)

0.39

Model 2

1.00

0.70 (0.49,1.00)

0.92 (0.61,1.25)

0.43

Hypertriglyceridemia (women)

Crude

1.00

0.84 (0.57,1.24)

0.85 (0.58,1.25)

0.40

Model 1

1.00

0.81 (0.54,1.19)

0.87 (0.59,1.28)

0.47

Model 2

1.00

0.80 (0.53,1.18)

0.88 (0.60,1.13)

0.50

Hypertriglyceridemia (men)

Crude

1.00

0.64 (0.29,1.42)

0.96 (0.42,2.20)

0.91

Model 1

1.00

0.63 (0.28,1.41)

0.95 (0.41,2.19)

0.90

Model 2

1.00

0.60 (0.26,1.38)

0.96 (0.42,2.23)

0.92

Hypertension (total)

Crude

1.00

0.64 (0.39,1.05)

1.00 (0.64,1.58)

0.98

Model 1

1.00

0.56 (0.33,0.95)

1.07 (0.66,1.74)

0.80

Model 2

1.00

0.56 (0.33,0.95)

1.04 (0.63,1.69)

0.91

Hypertension (women)

Crude

1.00

0.65 (0.37,1.12)

1.01 (0.62,1.66)

0.98

Model 1

1.00

0.58 (0.33,1.02)

1.10 (0.65,1.86)

0.76

Model 2

1.00

0.57 (0.32,1.02)

1.06 (0.63,1.80)

0.87

Hypertension (men)

Crude

1.00

0.66 (0.21,2.08)

0.77 (0.24,2.43)

0.64

Model 1

1.00

0.56 (0.17,1.85)

0.64 (0.19,2.14)

0.46

Model 2

1.00

0.61 (0.18,2.06)

0.64 (0.19,2.18)

0.48

Hyperglycemia (total)

Crude

1.00

1.06 (0.76,1.48)

1.13 (0.81,1.58)

0.46

Model 1

1.00

1.02 (0.72,1.44)

1.17 (0.83,1.67)

0.36

Model 2

1.00

1.02 (0.72,1.45)

1.15 (0.81,1.64)

0.42

Hyperglycemia (women)

Crude

1.00

0.99 (0.68,1.43)

1.12 (0.78,1.62)

0.54

Model 1

1.00

0.94 (0.64,1.38)

1.17 (0.80,1.71)

0.42

Model 2

1.00

0.94 (0.64,1.38)

1.15 (0.78,1.68)

0.49

Hyperglycemia (men)

Crude

1.00

1.15 (0.52,2.56)

0.85 (0.37,1.96)

0.71

Model 1

1.00

1.33 (0.58,3.07)

0.94 (0.39,2.25)

0.91

Model 2

1.00

1.44 (0.60,3.41)

0.94 (0.39,2.28)

0.91

Low HDL-C (total)

Crude

1.00

1.23 (0.88,1.71)

0.92 (0.66,1.29)

0.63

Model 1

1.00

1.26 (0.89,1.78)

0.97 (0.69,1.37)

0.87

Model 2

1.00

1.26 (0.89,1.78)

0.97 (0.68,1.37)

0.86

Low HDL-C (women)

Crude

1.00

1.25 (0.87,1.82)

0.95 (0.66,1.37)

0.81

Model 1

1.00

1.27 (0.87,1.85)

0.93 (0.64,1.34)

0.72

Model 2

1.00

1.27 (0.87,1.84)

0.92 (0.64,1.34)

0.70

Low HDL-C (men)

Crude

1.00

1.29 (0.56,2.95)

0.73 (0.30,1.78)

0.51

Model 1

1.00

1.41 (0.60,3.29)

0.73 (0.29,1.83)

0.52

Model 2

1.00

1.50 (0.63,3.58)

0.71 (0.28,1.80)

0.50

Abdominal obesity (total)

Crude

1.00

0.98 (0.70,1.37)

1.17 (0.83,1.63)

0.36

Model 1

1.00

0.87 (0.56,1.36)

1.17 (0.75,1.84)

0.49

Model 2

1.00

0.87 (0.56,1.36)

1.14 (0.72,1.79)

0.58

Abdominal obesity (women)

Crude

1.00

0.97 (0.67,1.40)

1.28 (0.89,1.85)

0.19

Model 1

1.00

0.88 (0.60,1.31)

1.41 (0.96,2.08)

0.09

Model 2

1.00

0.89 (0.60,1.33)

1.36 (0.92,2.01)

0.14

Abdominal obesity (men)

Crude

1.00

1.04 (0.40,2.75)

0.47 (0.15,1.52)

0.23

Model 1

1.00

0.93 (0.34,2.50)

0.42 (0.13,1.37)

0.16

Model 2

1.00

0.76 (0.27,2.17)

0.41 (0.12,1.42)

0.16

Metabolic syndrome (total)

Crude

1.00

0.98 (0.68,1.40)

1.02 (0.71,1.46)

0.90

Model 1

1.00

0.89 (0.60,1.31)

1.06 (0.71,1.57)

0.78

Model 2

1.00

0.89 (0.60,1.32)

1.04 (0.70,1.54)

0.86

Metabolic syndrome (women)

Crude

1.00

1.06 (0.72,1.56)

1.15 (0.78,1.68)

0.48

Model 1

1.00

0.99 (0.66,1.49)

1.22 (0.82,1.83)

0.33

Model 2

1.00

0.99 (0.66,1.49)

1.19 (0.79,1.78)

0.41

Metabolic syndrome (men)

Crude

1.00

1.15 (0.46,2.90)

0.52 (0.17,1.54)

0.27

Model 1

1.00

1.20 (0.45,3.15)

0.46 (0.15,1.44)

0.20

Model 2

1.00

1.29 (0.48,3.50)

0.43 (0.14,1.39)

0.18